A Cost-Benefit Analysis of a Mandatory Premarital Rubella-Antibody Screening Program
Authors:
- Matthew E. FarberMFMatthew E. Farber
- Stan N. FinkelsteinSFStan N. Finkelstein
- 12 April 1979
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 300 (15) , 856-859
Abstract
In 1969, two attenuated rubella vaccines were licensed for use in the United States. Since that time, the practice in this country has been to immunize school-age children to reduce the reservoir and spread of the virus.1 This policy is in contrast with the immunization strategy of the United Kingdom, which is to vaccinate only girls 10 to 14 years of age who do not have detectable hemagglutination-inhibiting antibodies to rubella virus.2 Although little has been written about the success of the British strategy, continual outbreaks of rubella in the United States are indicative of the difficulty in achieving herd . . .Keywords
This publication has 9 references indexed in Scilit:
- Rubella-Vaccinated StudentsJAMA, 1978
- Failure of rubella immunization among adolescent femalesThe Journal of Pediatrics, 1977
- Benefit-Cost Analysis of Rubella Vaccination PolicyNew England Journal of Medicine, 1976
- Rubella1976
- Rubella Immunization: A Five-Year Progress ReportNew England Journal of Medicine, 1974
- Inadvertent rubella vaccination of pregnant women. Fetal risk in 215 cases1973
- Underreporting of Viral HepatitisGastroenterology, 1973
- Failure of Rubella Herd Immunity during an EpidemicNew England Journal of Medicine, 1973
- POST-PARTUM VACCINATION OF RUBELLA-SUSCEPTIBLE WOMENThe Lancet, 1970